2026 medical update on MSC therapy for diabetic foot ulcers: M2 macrophage polarization, EXO-miR3671 angiogenesis, hydrogel delivery, UC-MSC vs ADSC head-to-head, 47-RCT meta-analysis, and cost-effectiveness vs amputation in Thailand.
Zimislecel (VX-880) is the first stem cell-derived islet therapy to reach the FDA, and the September 2025 NEJM paper showed 12 of 12 patients achieving insulin independence. Here’s what it means for T1D patients in 2026, who qualifies, and what options exist in Thailand now.
Diabetic wounds that refuse to heal affect hundreds of thousands of Thais. Discover how exosome therapy and MSC treatment are giving patients a real path to recovery.
Diabetes affects millions across Thailand. Can stem cell therapy help reverse it? Our Bangkok clinic shares real patient outcomes, THB pricing, and what the latest research says about stem cells for diabetes in 2026.
In a landmark development for stem cell research and diabetes treatment, Vertex Pharmaceuticals has achieved remarkable success with their investigational therapy VX-880 for type 1 diabetes (T1D). This breakthrough, based on longstanding research from Harvard Stem Cell Institute’s Melton Lab, represents one of the first practical applications of embryonic stem...
Bienvenue dans notre article sur la médecine régénératrice avancée. Dans cet article, nous allons explorer les dernières avancées de cette branche de la médecine qui a révolutionné la manière dont nous traitons les maladies et les blessures. Nous allons également examiner comment la médecine régénératrice avancée peut aider à régénérer...
Ученые разрабатывают многообещающий подход к лечению диабета 1 типа с помощью стволовых клеток для создания клеток, продуцирующих инсулин (называемых бета-клетками), которые могут заменить нефункциональные клетки поджелудочной железы. (далее…)
Russian 
English 
Chinese 
French